Introduction: Alzheimer’s disease (AD) manifests as progressive hippocampal neurodegeneration coupled with deteriorating cognitive performance. Although brain-derived neurotrophic factor (BDNF) exerts neuroprotective effects, its translational potential remains constrained. Objectives: This study evaluated whether BDNF-overexpressing adipose-derived mesenchymal stem cells (BDNF-ADSCs) exert neuroprotective effects in an AD mouse model. Methods: AD-like hippocampal injury was induced by stereotaxic injection of Aβ1–42 into the CA1 region of mice, followed by local transplantation of BDNF-ADSCs. Behavioral tests assessed anxiety-like behavior and cognitive function. Histological analysis evaluated hippocampal neuronal integrity, and apoptosis-related proteins were examined. Results: BDNF-ADSC transplantation significantly alleviated anxiety-like behavior and spatial learning and memory impairments induced by Aβ1–42. Histological analyses demonstrated reduced hippocampal neuronal loss and partial restoration of hippocampal cytoarchitecture. Moreover, Aβ1–42 markedly increased Bax expression and caspase-3 activation while decreasing Bcl-2 levels, whereas BDNF-ADSCs reversed these alterations by suppressing pro-apoptotic signaling and enhancing anti-apoptotic protein expression. Conclusion: BDNF-ADSCs protect against Aβ1–42-induced hippocampal injury and cognitive impairment, partly via modulation of the Bax/Bcl-2/caspase-3 apoptotic pathway, highlighting their potential as a cell-based therapeutic strategy for AD.